Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127818021 | 12781802 | 1 | I | 20151027 | 20160919 | 20160926 | 20160926 | EXP | FR-ABBVIE-16P-056-1738593-00 | ABBVIE | 24.00 | YR | F | Y | 0.00000 | 20160926 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127818021 | 12781802 | 1 | PS | DEPAKOTE | DIVALPROEX SODIUM | 1 | Oral | U | UNKNOWN | 18723 | 1 | G | |||||||
| 127818021 | 12781802 | 2 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | U | UNKNOWN | 0 | 7 | G | |||||||
| 127818021 | 12781802 | 3 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | U | UNKNOWN | 0 | 10 | G | |||||||
| 127818021 | 12781802 | 4 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | U | UNKNOWN | 0 | 16 | G | |||||||
| 127818021 | 12781802 | 5 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | U | UNKNOWN | 0 | 8 | G | |||||||
| 127818021 | 12781802 | 6 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | U | UNKNOWN | 0 | 7 | G | |||||||
| 127818021 | 12781802 | 7 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | U | UNKNOWN | 0 | 18 | G | |||||||
| 127818021 | 12781802 | 8 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | U | UNKNOWN | 0 | 11 | G | |||||||
| 127818021 | 12781802 | 9 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | U | UNKNOWN | 0 | 4 | DF | |||||||
| 127818021 | 12781802 | 10 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | U | UNKNOWN | 0 | 11 | DF | |||||||
| 127818021 | 12781802 | 11 | SS | TERCIAN | CYAMEMAZINE | 1 | Oral | U | 0 | ||||||||||
| 127818021 | 12781802 | 12 | SS | TRANXENE T-TAB | CLORAZEPATE DIPOTASSIUM | 1 | Oral | U | 0 | 20 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127818021 | 12781802 | 1 | Suicide attempt |
| 127818021 | 12781802 | 2 | Suicide attempt |
| 127818021 | 12781802 | 11 | Suicide attempt |
| 127818021 | 12781802 | 12 | Suicide attempt |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127818021 | 12781802 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127818021 | 12781802 | Alanine aminotransferase increased | |
| 127818021 | 12781802 | Analgesic drug level increased | |
| 127818021 | 12781802 | Gamma-glutamyltransferase increased | |
| 127818021 | 12781802 | Somnolence | |
| 127818021 | 12781802 | Toxicity to various agents | |
| 127818021 | 12781802 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127818021 | 12781802 | 1 | 20151027 | 20151027 | 0 | |
| 127818021 | 12781802 | 2 | 20151027 | 20151027 | 0 | |
| 127818021 | 12781802 | 3 | 20151101 | 20151101 | 0 | |
| 127818021 | 12781802 | 4 | 20151104 | 20151104 | 0 | |
| 127818021 | 12781802 | 5 | 20160215 | 20160215 | 0 | |
| 127818021 | 12781802 | 6 | 20160225 | 20160225 | 0 | |
| 127818021 | 12781802 | 7 | 20160314 | 20160314 | 0 | |
| 127818021 | 12781802 | 8 | 20160630 | 20160630 | 0 | |
| 127818021 | 12781802 | 9 | 20160707 | 20160707 | 0 | |
| 127818021 | 12781802 | 10 | 20160904 | 20160904 | 0 | |
| 127818021 | 12781802 | 11 | 20151027 | 20151027 | 0 | |
| 127818021 | 12781802 | 12 | 20160630 | 20160630 | 0 |